(S (NP (JJ Clinical) (NNS researchers)) (VP (VP (VBP use) (NP (NN disease) (NN progression) (NNS models)) (S (VP (TO to) (VP (VB understand) (NP (JJ patient) (NN status)))))) (CC and) (VP (VBP characterize) (NP (NN progression) (NNS patterns)) (PP (IN from) (NP (JJ longitudinal) (NN health) (NNS records))))) (. .))
(S (NP (NP (CD One) (NN approach)) (PP (IN for) (NP (NN disease) (NN progression) (NN modeling)))) (VP (VBZ is) (S (VP (TO to) (VP (VB describe) (NP (JJ patient) (NN status)) (S (VP (VBG using) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS states)) (SBAR (WHNP (WDT that)) (S (VP (VBP represent) (NP (JJ distinctive) (NNS distributions)) (PP (IN over) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (VBN observed) (NNS measures))))))))))))))))) (. .))
(S (NP (NP (NP (NML (VBN Hidden) (NNP Markov)) (NNS models)) (-LRB- -LRB-) (NP (NNS HMMs)) (-RRB- -RRB-)) (CC and) (NP (PRP$ its) (NNS variants))) (VP (VBP are) (NP (NP (DT a) (NN class)) (PP (IN of) (NP (NP (NNS models)) (SBAR (IN that) (S (NP (DT both)) (VP (VP (VBP discover) (NP (DT these) (NNS states))) (CC and) (VP (VB make) (NP (NP (NNS inferences)) (PP (IN of) (NP (NN health) (NNS states)))) (PP (IN for) (NP (NNS patients))))))))))) (. .))
(S (PP (IN Despite) (NP (NP (DT the) (NNS advantages)) (PP (IN of) (S (VP (VBG using) (NP (DT the) (NNS algorithms)) (PP (IN for) (S (VP (VBG discovering) (NP (JJ interesting) (NNS patterns)))))))))) (, ,) (NP (PRP it)) (ADVP (RB still)) (VP (VBZ remains) (ADJP (JJ challenging) (PP (IN for) (NP (JJ medical) (NNS experts)))) (S (VP (TO to) (VP (VP (VB interpret) (NP (NN model) (NNS outputs))) (, ,) (VP (VB understand) (NP (JJ complex) (NN modeling) (NNS parameters))) (, ,) (CC and) (ADVP (RB clinically)) (VP (VB make) (NP (NP (NN sense)) (PP (IN of) (NP (DT the) (NNS patterns))))))))) (. .))
(S (S (VP (TO To) (VP (VB tackle) (NP (DT these) (NNS problems))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (DT a) (NN design) (NN study)) (PP (IN with) (NP (NP (JJ clinical) (NNS scientists)) (, ,) (NP (NNS statisticians)) (, ,) (CC and) (NP (NN visualization) (NNS experts)))) (, ,) (PP (IN with) (NP (DT the) (NN goal) (S (VP (TO to) (VP (VB investigate) (NP (NP (NP (NN disease) (NN progression) (NNS pathways)) (PP (IN of) (NP (JJ chronic) (NNS diseases)))) (, ,) (ADVP (RB namely)) (NP (NP (NML (NN type) (CD 1)) (NN diabetes) (PRN (-LRB- -LRB-) (NP (NN T1D)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP Huntington) (POS 's)) (NN disease)) (, ,) (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (, ,) (CC and) (NP (NP (JJ chronic) (JJ obstructive) (JJ pulmonary) (NN disease)) (-LRB- -LRB-) (NP (NN COPD)) (-RRB- -RRB-)))))))))) (. .))
(S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (PRP we)) (VP (VBP introduce) (NP (NP (NNP DPVis)) (SBAR (WHNP (WDT which)) (S (ADVP (RB seamlessly)) (VP (VBZ integrates) (NP (NP (NN model) (NNS parameters) (CC and) (NNS outcomes)) (PP (IN of) (NP (NNPS HMMs)))) (PP (IN into) (NP (ADJP (JJ interpretable) (CC and) (JJ interactive)) (NNS visualizations)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNP DPVis)) (VP (VBZ is) (ADJP (JJ successful) (PP (IN in) (S (VP (VP (VBG evaluating) (NP (NN disease) (NN progression) (NNS models))) (, ,) (VP (ADVP (RB visually)) (VBG summarizing) (NP (NN disease) (NNS states))) (, ,) (VP (ADVP (RB interactively)) (VBG exploring) (NP (NP (NN disease) (NN progression) (NNS patterns)) (, ,) (CC and) (NP (NN building)))) (, ,) (VP (VBG analyzing)) (, ,) (CC and) (VP (VBG comparing) (NP (ADJP (RB clinically) (JJ relevant)) (NN patient) (NNS subgroups))))))))))) (. .))
